Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant

MLA

Annalisa Ruggeri, et al. “Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin as Graft- versus-Host Disease Prophylaxis in Haploidentical Transplant.” Haematologica, vol. 102, no. 2, Feb. 2017. EBSCOhost, https://doi.org/10.3324/haematol.2016.151779.

APA

Annalisa Ruggeri, Yuqian Sun, Myriam Labopin, Andrea Bacigalupo, Francesca Lorentino, William Arcese, Stella Santarone, Zafer Gülbas, Didier Blaise, Giuseppe Messina, Ardeshi Ghavamzadeh, Florent Malard, Benedetto Bruno, Jose Luis Diez-Martin, Yener Koc, Fabio Ciceri, Mohamad Mohty, & Arnon Nagler. (2017). Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant. Haematologica, 102(2). https://doi.org/10.3324/haematol.2016.151779

Chicago

Annalisa Ruggeri, Yuqian Sun, Myriam Labopin, Andrea Bacigalupo, Francesca Lorentino, William Arcese, Stella Santarone, et al. 2017. “Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin as Graft- versus-Host Disease Prophylaxis in Haploidentical Transplant.” Haematologica 102 (2). doi:10.3324/haematol.2016.151779.